GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Spectranetics Corp (NAS:SPNC) » Definitions » Total Liabilities

The Spectranetics (The Spectranetics) Total Liabilities : $392.2 Mil (As of Jun. 2017)


View and export this data going back to 1992. Start your Free Trial

What is The Spectranetics Total Liabilities?

The Spectranetics's Total Liabilities for the quarter that ended in Jun. 2017 was $392.2 Mil.

The Spectranetics's quarterly Total Liabilities declined from Dec. 2016 ($355.76 Mil) to Mar. 2017 ($355.28 Mil) but then increased from Mar. 2017 ($355.28 Mil) to Jun. 2017 ($392.16 Mil).

The Spectranetics's annual Total Liabilities increased from Dec. 2014 ($295.68 Mil) to Dec. 2015 ($351.03 Mil) and increased from Dec. 2015 ($351.03 Mil) to Dec. 2016 ($355.76 Mil).


The Spectranetics Total Liabilities Historical Data

The historical data trend for The Spectranetics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Spectranetics Total Liabilities Chart

The Spectranetics Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.07 27.16 295.68 351.03 355.76

The Spectranetics Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 349.01 348.95 355.76 355.28 392.16

The Spectranetics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

The Spectranetics's Total Liabilities for the fiscal year that ended in Dec. 2016 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=66.942+(284.759+1.688
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+2.366+0)
=355.8

Total Liabilities=Total Assets (A: Dec. 2016 )-Total Equity (A: Dec. 2016 )
=430.078-74.323
=355.8

The Spectranetics's Total Liabilities for the quarter that ended in Jun. 2017 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=74.206+(313.628+1.656
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+2.671+0)
=392.2

Total Liabilities=Total Assets (Q: Jun. 2017 )-Total Equity (Q: Jun. 2017 )
=433.353-41.192
=392.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Spectranetics Total Liabilities Related Terms

Thank you for viewing the detailed overview of The Spectranetics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


The Spectranetics (The Spectranetics) Business Description

Traded in Other Exchanges
N/A
Address
Spectranetics manufactures and sells single-use medical devices used in minimally invasive cardiovascular procedures. The firm operates in the three categories: vascular intervention, lead management, and laser, service, and other. The vascular intervention business contributes the majority of revenue and sells laser and aspiration catheters, balloon catheters, and support catheters. The lead management business sells devices used to remove pacemaker and defibrillator cardiac leads. The laser, service, and other business includes a laser system for cardiovascular procedures. Spectranetics generates the vast majority of its revenue in the United States.
Executives
Todd C Schermerhorn director C/O C.R BARD INC, 730 CENTRAL AVE, MURRAY HILL NJ 07974
R John Fletcher director C/O VYANT BIO, INC., 201 ROUTE 17 NORTH, 2ND FLOOR, RUTHERFORD NJ 07070
William C Jennings director 108 CHERRY HILL DRIVE, BEVERLY MA 01915-1053
B Kristine Johnson director 366 FERNDALE RD S, WAYZATA MN 55391
Scott William Drake director, officer: President, CEO 9965 FEDERAL DRIVE, COLORADO SPRINGS CO 80921
Maria Sainz director C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Shahriar Matin officer: Chief Operating Officer 96 TALAMINE COURT, COLORADO SPRINGS CO 80907
Stacy Powell Mcmahan officer: CFO 1000 CRANBERRY WOODS DRIVE, CRANBERRY TOWNSHIP PA 16066
Anne Melissa Dowling director 9965 FEDERAL DRIVE, COLORADO SPRINGS CO 80921
Jonathan Will Mcguire officer: COO 96 TALAMINE COURT, COLORADO SPRINGS CO 80907
Stephen D Okland officer: Vice President of Sales 96 TALAMINE COURT, COLORADO SPRINGS CO 80907
Martin T Hart director 2401 EAST 2ND AVE., SUITE 250, DENVER CO 80206